           |
 |
HEMOPHILIA.ORG
> BLEEDING DISORDERS INFO CENTER >
BLOOD SAFETY > PATIENT NOTIFICATION SYSTEM
Blood Safety | Hepatitis
| HIV | HIV/AIDS
FAQs |
Patient Notification System
Patient Notification System
The industry-wide Patient Notification System informs people when a blood
product is withdrawn or recalled.
Everyone should register with the Patient Notification System so they can
be directly notified when adverse conditions occur with blood products.
The system is being administered by the National Notification Center. The
identity of those individuals who have registered is completely confidential.
Participating companies involved in the system are:
Alpha Therapeutics
Baxter Healthcare
Bayer Corporation
Aventis Behring
Genetics Institute
The American Red Cross
Each person who registers with the Patient Notification System will select
how they wish to be notifiedtelephone, express delivery letter, fax
or e-mail. All participants will then receive a follow-up first-class letter
back-up. Participants can also select which products they wish to be notified
about.
The system is available by telephone for updates and news at 800-UPDATE-U.
There is also a Web site at www.NOTIFY1.com.
Register with the Patient Notification System now!
by phone: 888-873-2838
(888-UPDATE-U)
online Enrollment: www.NOTIFY1.com
fax registration forms
to: 1-800-442-2906
mail registration forms
to:
National Notification Center
20 N. Meridian Street, Suite 300
Indianapolis, IN 46204
Register now to be directly notified of a recall or withdrawal. Stay informed!
Disclaimer
The information contained on the NHF web site is provided for your general
information only. NHF does not give medical advice or engage in the practice
of medicine. NHF under no circumstances recommends particular treatment
for specific individuals and in all cases recommends that you consult your
physician or local treatment center before pursuing any course of treatment.
All information and content on this web site
are protected by copyright. All rights are reserved. Users are prohibited
from modifying, copying, distributing, transmitting, displaying, publishing,
selling, licensing, creating derivative works, or using any information
available on or through the site for commercial or public purposes.
|